Skip to main content

Table 2 Characteristics of respondents using desferrioxamine

From: An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use

31. Characteristics

Respondents using desferrioxamine (N = 1573)

Age N (%)

 

<10

329 (21.5)

10–18

464 (30.3)

>18

739 (48.2)

Male N (%)

765 (49.0)

Receiving blood transfusions N (%)

1564 (99.6)

Complications N (%)

 

Heart disease

154 (11.2)

Liver disease

258 (18.8)

Diabetes

133 (9.7)

Thyroid problem

85 (6.3)

32. Mean age at diagnosis, months (SD)

19.1 (28.4)